Cargando…
Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi
CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinica...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773059/ https://www.ncbi.nlm.nih.gov/pubmed/33409216 http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20 |
_version_ | 1783629988581343232 |
---|---|
author | Kirtana, J Kumar, Arvind Kumar, Swasthi S. Singh, Anupam K. Shankar, Sujay Halkur Sharma, Amrit Kumar, Amit Kaur, Ravneet Khan, Maroof A. Ranjan, Piyush Sethi, Prayas Chakravarthy, Avinash Srivastava, Achal K. Wig, Naveet |
author_facet | Kirtana, J Kumar, Arvind Kumar, Swasthi S. Singh, Anupam K. Shankar, Sujay Halkur Sharma, Amrit Kumar, Amit Kaur, Ravneet Khan, Maroof A. Ranjan, Piyush Sethi, Prayas Chakravarthy, Avinash Srivastava, Achal K. Wig, Naveet |
author_sort | Kirtana, J |
collection | PubMed |
description | CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinical presentation with progression of disease and the duration of resolution of symptoms. SETTINGS AND DESIGN: This is a retrospective study that has been conducted at a designated COVID -19 medical ward at AIIMS, New Delhi METHODS AND MATERIAL: Fifty healthcare workers and their dependents who were admitted with asymptomatic and mild COVID-19 infection were included. Their records were retrospectively reviewed, entered into a predesigned proforma and analyzed. RESULTS: A total of 50 participants were included in the study of which 70% were healthcare workers. The patients were admitted with mild COVID illness out of which 22 (44%) were males. Most common symptom at presentation was fever (72%). Among patients who had mild disease versus those who progressed to moderate illness (n = 3), the patients with moderate illness were older [mean (SD): 57.33 (10.21) vs. 36.13 (14.05); P = 0.014] and had a longer duration of hospital stay [17 (1.41) days vs. 11.20 (3.86) days; P = 0.04]. Inflammatory markers, C-Reactive Protein (CRP) [2.46 vs. 0.20 (P = 0.024)], and Ferritin [306.15 vs. 72.53 (P = 0.023)] were higher in patients with moderate illness. There is also a significant correlation between the number of days taken for symptoms to resolve with Serum Ferritin (P = 0.007), CRP (P = 0.0256), and neutrophil lymphocyte ratio (NLR) (P = 0.044). CONCLUSIONS: Acute phase reactants/Inflammatory markers serve as good indicators of time taken to resolution of symptoms in acute COVID infection. NLR is a simple and inexpensive method to provide insight into symptomatic phase. These may be utility tools for primary care physician in the management in periphery and timely decision. |
format | Online Article Text |
id | pubmed-7773059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-77730592021-01-05 Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi Kirtana, J Kumar, Arvind Kumar, Swasthi S. Singh, Anupam K. Shankar, Sujay Halkur Sharma, Amrit Kumar, Amit Kaur, Ravneet Khan, Maroof A. Ranjan, Piyush Sethi, Prayas Chakravarthy, Avinash Srivastava, Achal K. Wig, Naveet J Family Med Prim Care Original Article CONTEXT: Comprehensive management of mild COVID infection calls for better understanding of symptomatology in these group of patients as well as early identification and close monitoring of patients at risk, data on which is limited. AIM: To study association between inflammatory markers and clinical presentation with progression of disease and the duration of resolution of symptoms. SETTINGS AND DESIGN: This is a retrospective study that has been conducted at a designated COVID -19 medical ward at AIIMS, New Delhi METHODS AND MATERIAL: Fifty healthcare workers and their dependents who were admitted with asymptomatic and mild COVID-19 infection were included. Their records were retrospectively reviewed, entered into a predesigned proforma and analyzed. RESULTS: A total of 50 participants were included in the study of which 70% were healthcare workers. The patients were admitted with mild COVID illness out of which 22 (44%) were males. Most common symptom at presentation was fever (72%). Among patients who had mild disease versus those who progressed to moderate illness (n = 3), the patients with moderate illness were older [mean (SD): 57.33 (10.21) vs. 36.13 (14.05); P = 0.014] and had a longer duration of hospital stay [17 (1.41) days vs. 11.20 (3.86) days; P = 0.04]. Inflammatory markers, C-Reactive Protein (CRP) [2.46 vs. 0.20 (P = 0.024)], and Ferritin [306.15 vs. 72.53 (P = 0.023)] were higher in patients with moderate illness. There is also a significant correlation between the number of days taken for symptoms to resolve with Serum Ferritin (P = 0.007), CRP (P = 0.0256), and neutrophil lymphocyte ratio (NLR) (P = 0.044). CONCLUSIONS: Acute phase reactants/Inflammatory markers serve as good indicators of time taken to resolution of symptoms in acute COVID infection. NLR is a simple and inexpensive method to provide insight into symptomatic phase. These may be utility tools for primary care physician in the management in periphery and timely decision. Wolters Kluwer - Medknow 2020-10-05 /pmc/articles/PMC7773059/ /pubmed/33409216 http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20 Text en Copyright: © 2020 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kirtana, J Kumar, Arvind Kumar, Swasthi S. Singh, Anupam K. Shankar, Sujay Halkur Sharma, Amrit Kumar, Amit Kaur, Ravneet Khan, Maroof A. Ranjan, Piyush Sethi, Prayas Chakravarthy, Avinash Srivastava, Achal K. Wig, Naveet Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title | Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title_full | Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title_fullStr | Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title_full_unstemmed | Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title_short | Mild COVID-19 infection-predicting symptomatic phase and outcome: A study from AIIMS, New Delhi |
title_sort | mild covid-19 infection-predicting symptomatic phase and outcome: a study from aiims, new delhi |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773059/ https://www.ncbi.nlm.nih.gov/pubmed/33409216 http://dx.doi.org/10.4103/jfmpc.jfmpc_1610_20 |
work_keys_str_mv | AT kirtanaj mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT kumararvind mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT kumarswasthis mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT singhanupamk mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT shankarsujayhalkur mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT sharmaamrit mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT kumaramit mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT kaurravneet mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT khanmaroofa mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT ranjanpiyush mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT sethiprayas mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT chakravarthyavinash mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT srivastavaachalk mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi AT wignaveet mildcovid19infectionpredictingsymptomaticphaseandoutcomeastudyfromaiimsnewdelhi |